Stem Cell Clinical Trials for Spinal Cord Injury: Readiness, Reluctance, Redefinition

Stem Cell Reviews and Reports

Volumn 7, Issue 4, 2011, Pages 997-1005

  Illes, J ^a   Reimer, J C ^a   Kwon, B K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; ETHICS; FEMALE; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; MALE; MENTAL CAPACITY; METHODOLOGY; MIDDLE AGED; SPINAL CORD INJURY; STANDARD; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TIME;

ADULT; CLINICAL TRIALS AS TOPIC; COHORT STUDIES; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFORMED CONSENT; MALE; MENTAL COMPETENCY; MIDDLE AGED; SPINAL CORD INJURIES; STEM CELL RESEARCH; STEM CELL TRANSPLANTATION; TIME FACTORS; YOUNG ADULT;

EID: 82355164403     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-011-9259-1     Document Type: Article

References (35)

1. Tetzlaff, W., Okon, E., Karimi-Abdolrezaee, S., et al. (2010). A systematic review of cellular transplantation therapies for spinal cord injury. Journal of Neurotrama. doi: 10. 1089/neu. 2009. 1177.
2. Kwon, B., Sekhon, L., & Fehlings, M. (2010). Emerging repair, regeneration and translational research advances for spinal cord injury. Spine, 35(21S), S263-S270.
3. Sahni, V., & Kessler, J. (2010). Stem cell therapies for spinal cord injury. Nature Reviews Neurology, 6, 363-372.
4. International Campaign for Cures of spinal cord injury paralysis. (2010). General Information. http://www.campaignforcure.org/iccp/index.php?option=com_content&task=view&id=13&Itemid=28. Accessed January 2010.
5. Downey, R., & Geranser, R. (2008). Stem cell research, publics' and stakeholder views. Health Law Review, 16(2), 9-84.
6. Abma, T. (2005). Patient participation in health research: research with and for people with spinal cord injuries. Qualitative Health Research, 15(10), 1310-1328.
7. Grunwell, J., Illes, J., & Karkazis, K. (2009). Advancing neuroregenerative medicine: A call for expanded collaboration between scientists and ethicists. Neuroethics, 2(1), 13-20.
8. Estores, I. (2003). The consumer's perspective and the professional literature: what do persons with spinal cord injury want? Journal of Rehabilitation Research and Development, 40(4), 93-98.
9. Anderson, K. (2003). Consideration of user priorities when developing neural prosthetics. Journal of Neural Engineering, 6(5), 1-3.
10. Kwon, B., Hillyer, J., & Tetzlaff, W. (2010). Translational research in spinal cord injury: a survey of opinion from the SCI community. Journal of Neurotrauma, 27, 21-33.
11. Geron initiates clinical trial of human embryonic stem cell-based therapy. (2010). Press release. http://www.geron.com/media/pressview.aspx?id=1235. Accessed 17 November 2010.
12. Keirstead, H. S., Nistor, G., Bernal, G., Totoiu, M., Cloutier, F., Sharp, K., et al. (2005). Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. Journal of Neuroscience, 11(19), 4694-4705.
13. Kumar, A. A., Kumar, S. R., Narayanan, R., Arul, K., & Baskaran, M. (2009). Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I/II clinical safety and primary efficacy data. Experimental and Clinical Transplantation, 7(4), 241-248.
14. Pal, R., Venkataramana, N. K., Bansal, A., et al. (2009). Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy, 11(7), 897-911.
15. Yoon, S. H., Shim, Y. S., Park, Y. H., et al. (2007). Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: Phase I/II clinical trial. Stem Cells, 25(8), 2066-2073.
16. Cristante, A. F., Barros-Filho, T. E., Tatsui, N., et al. (2009). Stem cells in the treatment of chronic spinal cord injury: Evaluation of somatosensitive evoked potentials in 39 patients. Spinal Cord, 47(10), 733-8.
17. Chernykh, E. R., Stupak, V. V., Muradov, G. M., et al. (2007). Application of autologous bone marrow stem cells in the therapy of spinal cord injury patients. Bulletin of Experimental Biology and Medicine, 143(4), 543-547.
18. Moviglia, G. A., Fernandez Viña, R., Brizuela, J. A., et al. (2006). Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy, 8(3), 202-209.
19. Lima, C., Escada, P., Pratas-Vital, J., et al. (2010). Olfactory mucosal autografts and rehabilitation for chronic traumatic spinal cord injury. Neurorehabilitation and Neural Repair, 24(1), 10-22.
20. Mackay-Sim, A., Féron, F., Cochrane, J., et al. (2008). Autologous olfactory ensheathing cell transplantation in human paraplegia: A 3-year clinical trial. Brain, 131(9), 2376-2386.
21. ReNeuron announces first patient treated in landmark stroke stem cell trial. (2010). Press Release. http://www.reneuron.com/news__events/news/document_260_237.php. Accessed 20 November 2010.
22. van Hedel, H. J., & Curt, A. (2006). Fighting for each segment: Estimating the clinical value of cervical and thoracic segments in SCI. J Neurotrauma, 23(11), 1621-1631.
23. Bradley, E., Curry, L., & Devers, K. (2007). Qualitative data analysis for health services research: developing taxonomy, themes, and theory. Health Services Research, 42(4), 1758-1772.
24. Thorne, S., Kirkham, S. R., O'Flynn-Magee, K. (2004) The analytic challenge in interpretative description. International Journal of Qualitative Methods. 3(1). Accessed 18 February 2011, http://www.ualberta.ca/%7Eiiqm/backissues/3_1/pdf/thorneetal.pdf.
25. Feudtner, C. (2008). Ethics in the midst of therapeutic evolution. Archives of Pediatric Adolescent Medicine, 162(9), 854-857.
26. Robertson, J. (2010). Embryo stem cell research: Ten years of controversy. The Journal of Law, Medicine and Ethics, 38(2), 191-203.
27. Taylor, C. (2010). Overseeing innovative therapy without mistaking it for research: a function based model based on old truths, new capacities and lessons learned from stem cells.). Embryo stem cell research: ten years of controversy.The Journal of Law, Medicine and Ethics, 38(2), 286-301.
28. Angiolillo, A. L., Simon, C., Kodish, E., Lange, B., Noll, R. B., Ruccione, K., et al. (2004). Staged informed consent for a randomized clinical trial in childhood leukemia: Impact on the consent process. Pediatric Blood Cancer, 42, 433-437.
29. Edner, M., Yamokoski, A., Wittman, P., & Kodish, E. (2007). Improving informed consent: Suggestions from parents. Pediatrics, 119(4), e849-e859.
30. Lavori, P., Sugarman, J., Hays, M., & Feussner, J. (1999). Improving informed consent in clinical trials: A duty to experiment. Controlled Clinical Trials, 20(2), 187-193.
31. Francis, V., Korsch, B. M., & Morris, M. J. (1969). Gaps in the doctor-patient communication: Patients' respond to medical advice. New England Journal of Medicine, 80(10), 535-540.
32. Joffe, S., Cook, E. F., Cleary, P. D., et al. (2001). Quality of informed consent in cancer clinical trials: A cross-sectional survey. Lancet, 358, 1771-1777.
33. Sugarman, J. (2010). Reflections on governance models for the clinical translation of stem cells. Journal of Law, Medicine and Ethics, 38(2), 251-256.
34. Wade, J., Donovan, J., Lane, J. A., Neal, D., & Hamdy, F. (2009). It's not just what you say, it's how you say it: opening the 'black box' of informed consent appointments in randomized controlled trials. Social Science and Medicine, 68, 2018-2028.
35. Barfield, R. C., & Church, C. (2005). Informed consent in pediatric clinical trials. Current Opinion in Pediatrics, 17(1), 20-24.